Rapid and accurate triage of patients presenting with chest pain to an emergency
department (ED) is critical to prevent ED overcrowding and unnecessary resource use in …

Cardiotoxicity is a growing concern in the oncology population. Transthoracic
echocardiography and multigated acquisition scans have been used for surveillance but are …

Objectives Cardiac troponin (cTn) is the key biomarker for diagnosis of acute coronary
syndrome (ACS). We performed a complete assessment of the high-sensitivity cardiac …

The high-sensitivity immunoassays for cardiac troponin I (hs-cTnI) and cardiac troponin T (hs-
cTnT) are actually recommended by all the most recent guidelines as gold standard …

Simple Summary Cancer therapy-related cardiac dysfunction (CTRCD) has been an urgent
medical issue in patients that receive breast cancer therapies including anthracycline-based …

The aim of this article review is to analyze some models and clinical issues related to the
implementation of accelerated diagnostic protocols based on specific cardiac biomarkers in …

Despite the evidence demonstrating the clinical utility of cardiac specific biomarkers in
improving cardiovascular risk evaluation in several clinical conditions, even the most recent …

Renal cell carcinoma, an aggressive malignancy, is often incidentally diagnosed. The
patient remains asymptomatic to the late stage of the disease, when the local or distant …

Natriuretic peptides (NP) play an essential role in heart failure (HF) regulation, and their
measurement has improved diagnostic and prognostic accuracy. Clinical symptoms and …

Serial cardiac troponin (cTn) testing on patients with symptoms suggestive of acute coronary
syndrome (ACS) is primarily to identify those patients with evolving myocardial injury. With …